Stockscreener 앱 받기
3.77
1.10%
-0.03
전일 마감가:
$3.80
열려 있는:
$3.87
하루 거래량:
80,879
Relative Volume:
0.24
시가총액:
$1.97M
수익:
-
순이익/손실:
$-53.12M
주가수익비율:
-0.0347
EPS:
-108.8
순현금흐름:
$-15.86M
1주 성능:
-17.04%
1개월 성능:
-10.30%
6개월 성능:
-90.97%
1년 성능:
-99.29%
1일 변동 폭
$3.65
$3.87
1주일 범위
$3.16
$4.21
52주 변동 폭
$3.16
$656.88
블루 워터 백신 Stock (ONCO) Company Profile
명칭
Onconetix Inc
전화
513-620-4101
주소
201 E. FIFTH STREET, CINCINNATI
ONCO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.77 | 2.52M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.69 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.08 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.63 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
574.03 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
293.98 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
블루 워터 백신 주식(ONCO)의 최신 뉴스
What drives Onconetix Inc. stock priceSuperior profit margins - jammulinksnews.com
Onconetix Inc. Stock Analysis and ForecastConsistent wealth multiplication - jammulinksnews.com
What makes Onconetix Inc. stock price move sharplyDaily Gain Forecast - Newser
What analysts say about Onconetix Inc. stockPhenomenal wealth increase - printweek.in
Is Onconetix Inc. a good long term investmentSuperior returns - PrintWeekIndia
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders - The Malaysian Reserve
Halper Sadeh investigates Onconetix, Waters, and Longevity Health Holdings mergers. - AInvest
Can Onconetix Inc. stock recover from recent declineFree Insider Trading Tips - Newser
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Onconetix Shares Plunge 22.52% Amid Dilutive Merger - AInvest
Onconetix, Ocuvex execute definitive merger agreement - TipRanks
ONCO Stock on the Rise: A Promising Investment - investchronicle.com
Onconetix Shares Collapse 19% as Merger Uncertainties Collide with Legal Risks - AInvest
Onconetix Merger: Navigating Legal Risks and Market Volatility - AInvest
ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders - The Globe and Mail
Onconetix Crashes 18% as Merger with Ocuvex Sparks Dilution Fears and Liquidity Concerns - AInvest
Onconetix to buy privately held Ocuvex Therapeutics (ONCO) - Seeking Alpha
Onconetix To Merge With Ocuvex Therapeutics - Nasdaq
Onconetix Soars 13.69% on Ocuvex Merger Announcement - AInvest
Onconetix and Ocuvex Therapeutics announce definitive merger agreement By Investing.com - Investing.com Nigeria
Onconetix and Ocuvex Therapeutics announce definitive merger agreement - Investing.com Australia
Onconetix, Inc. and Ocuvex Therapeutics, Inc. Announce Definitive Merger Agreement - Nasdaq
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement - GlobeNewswire
Major Biotech Merger: Ocuvex Takes 90% Control of Onconetix to Advance Ophthalmic Pipeline - Stock Titan
How Onconetix Inc. stock performs during market volatilitySafety First Trading Signals - Newser
Why Onconetix Inc. stock attracts strong analyst attentionFree Real-Time Stock Data - Newser
Onconetix Secures Nasdaq Listing with Panel Decision - TipRanks
Onconetix receives positive decision by Nasdaq Hearings Panel - TipRanks
Onconetix regains Nasdaq compliance after filing Q1 report - Investing.com
Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel - MarketScreener
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel - GlobeNewswire
Onconetix Avoids Nasdaq Delisting: Key Panel Decision Keeps Biotech Stock Listed - Stock Titan
Onconetix announces 1-for-85 reverse stock split - MSN
블루 워터 백신 (ONCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.44%
자본화:
|
볼륨(24시간):